Heparin The risk or severity of hyperkalemia can be increased when Heparin is combined with Itraconazole. Histrelin The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Histrelin. Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when...
Fondaparinux Omega-3 fatty acids may increase the anticoagulant activities of Fondaparinux. Heparin Omega-3 fatty acids may increase the anticoagulant activities of Heparin. Ibrutinib Omega-3 fatty acids may increase the antiplatelet activities of Ibrutinib. Icosapent ethyl Omega-3 fatty acids may increas...
c, After the assembly of the open-promoter complex, reactions were either immediately supplemented with NTPs (time point 0) or mixed with heparin and incubated for 1, 2, 4 and 8 min before the addition of NTPs. d, Reactions initiated from rrnBP1 were incubated for 3, 6 and 12 ...
receptor blockers, beta-receptor blockers, and aldosterone receptor antagonists are used in the treatment of heart failure. However, they cannot completely prevent the development of heart failure [5,6]. In addition, ultrafiltration treatment, heart resynchronization therapy (CRT), implantable cardiovert...
Huangqi Guizhi Wuwu decoction (HQGZWWD) has been used to treat and prevent deep vein thrombosis (DVT) in China. However, its potential mechanisms of action remain unclear. This study aimed to utilize network pharmacology and molecular docking technology
Skip to main contentSkip to article
Single-stranded DNA (ssDNA) commonly occurs as intermediates in DNA metabolic pathways. The ssDNA binding protein, RPA, not only protects the integrity of ssDNA, but also directs the downstream factor that signals or repairs the ssDNA intermediate. Howev
Potency and mechanism of action of AMP have presented in... M Pirtskhalava,B Vishnepolsky,M Grigolava 被引量: 0发表: 2020年 In vitro antimicrobial activity and mechanism of action of novel carbohydrate fatty acid derivatives against Staphylococcus aureus and MRSA This study investigates the ...
The use of blinatumomab can also affect a patient’s ability to drive and use machines.6 Mechanism of action Blinatumomab is a bispecific T-cell engager (BiTE) that targets CD19, an antigen expressed on the surface of B-cells, and CD3, an antigen expressed on the surface of T-cells.1 ...
Bismuth subsalicylate is an antidiarrheal and anti-inflammatory agent used for symptomatic treatment of nausea, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract.